Stock 2E40 PHAXIAM THERAPEUTICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights PHAXIAM Therapeutics S.A. Deutsche Boerse AG

Equities

2E40

FR001400K4B1

Delayed Deutsche Boerse AG
Other stock markets
 03:50:03 2024-07-16 pm EDT 		5-day change 1st Jan Change
1.898 EUR -1.15% Intraday chart for PHAXIAM Therapeutics S.A. +0.42% -57.35%
Jul. 03 Phaxiam: EPIC Bpifrance exceeds 25% of share capital CF
Jun. 28 Would you like some more inflation? Our Logo

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Phaxiam: fewer funds raised than expected
CF
Phaxiam: capital increase of ten million euros
CF
Phaxiam initiates trial in infective endocarditis
CF
PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus
CI
PHAXIAM Therapeutics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
PHAXIAM Therapeutics Completes Delisting of ADS From Nasdaq
MT
Global markets live: BAE Systems, HSBC, Nvidia, Tesla, Boeing...
Our Logo
Phaxiam to delist ADS from Nasdaq in March
CF
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHXM Stock
  4. 2E40 Stock
  5. News PHAXIAM Therapeutics S.A.
  6. Highlights